TSC1 and lymphangioleiomyomatosis: Similar findings have also been reported for facial angiofibromas, where half of individuals with TSC1/TSC2 pathogenic variants also presented with a second hit in the affected tissue as well as renal AMLs and LAM [116,120,121].